Abstract
Antibody neutralization of cytomegalovirus (CMV) entry into diverse cell types is a key consideration for development of vaccines and immunotherapeutics. CMV entry into fibroblasts differs significantly from entry into epithelial or endothelial cells: fibroblast entry is mediated by gB and gH/gL/gO, whereas both epithelial and endothelial cell entry require an additional pentameric complex (PC) comprised of gH/gL/UL128/UL130/UL131A. Because PC-specific antibodies in CMV-seropositive human sera do not affect fibroblast entry but potently block entry into epithelial or endothelial cells, substantially higher neutralizing potencies for CMV-positive sera are observed when assayed using epithelial cells as targets than when using fibroblasts. That certain sera exhibit similar discordances between neutralizing potencies measured using epithelial vs. endothelial cells (Gerna G. et al.J Gen Virol, 89:853–865, 2008) suggested that additional mechanistic differences may also exist between epithelial and endothelial cell entry. To further explore this issue, neutralizing potencies using epithelial and endothelial cells were simultaneously determined for eight CMV-positive human sera, CMV-hyperimmune globulin, and a panel of monoclonal or anti-peptide antibodies targeting specific epitopes in gB, gH, gH/gL, or the PC. No significant differences were observed between epithelial and endothelial neutralizing potencies of epitope-specific antibodies, CMV-hyperimmune globulin, or seven of the eight human sera. However, one human serum exhibited a six-fold higher potency for neutralizing entry into epithelial cells vs. endothelial cells. These results suggest that epitopes exist that are important for epithelial entry but are less critical, or perhaps dispensable, for endothelial cell entry. Their existence should be considered when developing monoclonal antibody therapies or subunit vaccines representing limited epitopes.
Highlights
In order to determine if qualitative or quantitative discordances exist in the ability of human CMV-positive sera to neutralize CMV entry into epithelial vs. endothelial cells, quantitative green fluorescent protein (GFP)based neutralizing assays were performed as described previously with minor modifications [9, 10]
Fusion occurs at the plasma membrane and is mediated by an interplay between the fusogenic glycoprotein B and a trimeric complex comprised of glycoproteins H, L, and O
Entry into epithelial, endothelial, and certain myeloid lineage cells involves endocytosis followed by endosomal acidification and, in addition to glycoprotein B (gB) and Glycoprotein H (gH)/Glycoprotein L (gL)/Glycoprotein O (gO), requires a pentameric complex (PC) comprised of gH/gL plus UL128, UL130, and UL131A [2,3,4,5]
Summary
In order to determine if qualitative or quantitative discordances exist in the ability of human CMV-positive sera to neutralize CMV entry into epithelial vs. endothelial cells, quantitative green fluorescent protein (GFP)based neutralizing assays were performed as described previously with minor modifications [9, 10]. For reasons that remain unclear, PC-specific antibodies often neutralize epithelial or endothelial cell entry with potencies two to three logs higher than those targeting the other complexes [6, 7].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.